 Irina Petrache
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 35 | 2024 | 288 | 9.810 |
Why?
| | Ceramides | 24 | 2025 | 118 | 5.260 |
Why?
| | alpha 1-Antitrypsin | 15 | 2023 | 108 | 5.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 24 | 2024 | 1040 | 4.590 |
Why?
| | Lung | 55 | 2025 | 4060 | 4.460 |
Why?
| | Endothelial Cells | 25 | 2025 | 785 | 4.170 |
Why?
| | Lung Injury | 12 | 2025 | 219 | 4.080 |
Why?
| | Apoptosis | 39 | 2025 | 2553 | 3.950 |
Why?
| | Smoking | 30 | 2020 | 1627 | 3.820 |
Why?
| | Cigarette Smoking | 8 | 2022 | 101 | 3.360 |
Why?
| | Smoke | 12 | 2021 | 141 | 3.060 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 103 | 2.830 |
Why?
| | Emphysema | 10 | 2023 | 106 | 2.450 |
Why?
| | Sphingolipids | 8 | 2025 | 77 | 2.420 |
Why?
| | Sphingomyelin Phosphodiesterase | 7 | 2025 | 26 | 2.420 |
Why?
| | alpha 1-Antitrypsin Deficiency | 8 | 2019 | 67 | 2.160 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 405 | 2.110 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 391 | 2.080 |
Why?
| | Acute Lung Injury | 4 | 2025 | 287 | 1.900 |
Why?
| | Vaping | 3 | 2023 | 60 | 1.570 |
Why?
| | Animals | 89 | 2025 | 36940 | 1.410 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 927 | 1.380 |
Why?
| | Mice | 58 | 2025 | 17787 | 1.360 |
Why?
| | Tobacco Products | 5 | 2021 | 138 | 1.350 |
Why?
| | Hypertension, Pulmonary | 9 | 2025 | 1910 | 1.340 |
Why?
| | Microvessels | 4 | 2021 | 88 | 1.320 |
Why?
| | Signal Transduction | 19 | 2020 | 5079 | 1.210 |
Why?
| | Oxidative Stress | 13 | 2020 | 1317 | 1.200 |
Why?
| | Cells, Cultured | 23 | 2021 | 4193 | 1.180 |
Why?
| | Autophagy | 7 | 2021 | 284 | 1.150 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1242 | 1.140 |
Why?
| | Mice, Inbred C57BL | 28 | 2025 | 5757 | 1.120 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 114 | 1.110 |
Why?
| | Disease Models, Animal | 16 | 2022 | 4295 | 1.060 |
Why?
| | Pneumonia | 5 | 2021 | 639 | 1.000 |
Why?
| | Lipopolysaccharides | 5 | 2025 | 886 | 0.990 |
Why?
| | Caspase 3 | 7 | 2016 | 246 | 0.980 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 436 | 0.970 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1086 | 0.960 |
Why?
| | Inflammation | 9 | 2025 | 2837 | 0.940 |
Why?
| | Membrane Proteins | 5 | 2022 | 1164 | 0.930 |
Why?
| | Hypoxia | 6 | 2020 | 1112 | 0.920 |
Why?
| | Adipose Tissue | 5 | 2017 | 635 | 0.900 |
Why?
| | MicroRNAs | 2 | 2022 | 692 | 0.900 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 261 | 0.890 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 179 | 0.880 |
Why?
| | Up-Regulation | 10 | 2020 | 843 | 0.880 |
Why?
| | Rats | 22 | 2017 | 5647 | 0.880 |
Why?
| | Endothelium | 4 | 2023 | 123 | 0.880 |
Why?
| | Humans | 100 | 2025 | 137585 | 0.870 |
Why?
| | Endocytosis | 3 | 2016 | 172 | 0.860 |
Why?
| | Vascular System Injuries | 1 | 2023 | 71 | 0.770 |
Why?
| | Mice, Knockout | 12 | 2025 | 3015 | 0.740 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.720 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.720 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.720 |
Why?
| | Phagocytosis | 3 | 2021 | 380 | 0.700 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2486 | 0.690 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 14 | 0.660 |
Why?
| | Glucosylceramides | 1 | 2019 | 6 | 0.650 |
Why?
| | Translocation, Genetic | 1 | 2020 | 105 | 0.650 |
Why?
| | Immunoglobulins | 1 | 2020 | 171 | 0.640 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 225 | 0.640 |
Why?
| | Glycoproteins | 1 | 2021 | 342 | 0.610 |
Why?
| | Estradiol | 3 | 2018 | 521 | 0.610 |
Why?
| | Epithelial Cells | 10 | 2022 | 1096 | 0.610 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 26 | 0.600 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 840 | 0.600 |
Why?
| | Macrophages | 4 | 2021 | 1547 | 0.600 |
Why?
| | Influenza, Human | 2 | 2022 | 622 | 0.590 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.580 |
Why?
| | Lysosomes | 2 | 2021 | 141 | 0.580 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 20 | 0.580 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 8 | 0.580 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 286 | 0.580 |
Why?
| | Lung Diseases | 4 | 2025 | 767 | 0.570 |
Why?
| | Sphingosine | 5 | 2015 | 46 | 0.570 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 434 | 0.570 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.560 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 6 | 0.560 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 652 | 0.560 |
Why?
| | Metformin | 1 | 2021 | 331 | 0.550 |
Why?
| | Thorax | 2 | 2022 | 50 | 0.540 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 422 | 0.540 |
Why?
| | Cell Death | 4 | 2019 | 374 | 0.510 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 163 | 0.510 |
Why?
| | Cell Movement | 4 | 2020 | 967 | 0.510 |
Why?
| | DNA Repair | 1 | 2018 | 231 | 0.490 |
Why?
| | Male | 44 | 2024 | 67762 | 0.490 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 14 | 0.480 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 71 | 0.470 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2426 | 0.470 |
Why?
| | Telemetry | 1 | 2015 | 40 | 0.470 |
Why?
| | DNA Damage | 1 | 2018 | 420 | 0.470 |
Why?
| | Cosmic Radiation | 1 | 2014 | 5 | 0.460 |
Why?
| | ADAM Proteins | 3 | 2022 | 61 | 0.460 |
Why?
| | Cytokines | 9 | 2019 | 2085 | 0.460 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2167 | 0.450 |
Why?
| | Oxidoreductases | 4 | 2011 | 92 | 0.450 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 85 | 0.440 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.440 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 283 | 0.440 |
Why?
| | Alginates | 1 | 2014 | 46 | 0.440 |
Why?
| | Palmitic Acids | 1 | 2014 | 10 | 0.440 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 15 | 0.440 |
Why?
| | Female | 35 | 2024 | 73304 | 0.430 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 81 | 0.430 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 77 | 0.430 |
Why?
| | Spinal Injuries | 1 | 2014 | 53 | 0.420 |
Why?
| | Enzyme Activation | 8 | 2015 | 810 | 0.420 |
Why?
| | Cell Proliferation | 9 | 2020 | 2475 | 0.420 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 129 | 0.420 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 176 | 0.410 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 6 | 0.390 |
Why?
| | Tracheostomy | 1 | 2014 | 133 | 0.390 |
Why?
| | Lysophospholipids | 5 | 2015 | 80 | 0.390 |
Why?
| | Nicotine | 1 | 2015 | 334 | 0.390 |
Why?
| | Interleukin-6 | 1 | 2016 | 778 | 0.380 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 225 | 0.380 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1114 | 0.370 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 352 | 0.360 |
Why?
| | Metabolomics | 5 | 2018 | 678 | 0.360 |
Why?
| | Estrogens | 1 | 2014 | 367 | 0.350 |
Why?
| | Photons | 1 | 2011 | 70 | 0.350 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 52 | 0.350 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 327 | 0.340 |
Why?
| | Exercise Therapy | 1 | 2015 | 443 | 0.340 |
Why?
| | Cell Differentiation | 2 | 2018 | 1991 | 0.340 |
Why?
| | Stress, Physiological | 1 | 2014 | 443 | 0.340 |
Why?
| | Virus Diseases | 2 | 2023 | 212 | 0.330 |
Why?
| | Adult Stem Cells | 1 | 2010 | 40 | 0.330 |
Why?
| | Hemodynamics | 1 | 2015 | 1113 | 0.330 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 58 | 0.320 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2057 | 0.320 |
Why?
| | Caspases | 3 | 2011 | 247 | 0.320 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 188 | 0.300 |
Why?
| | Phenotype | 7 | 2020 | 3196 | 0.300 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 346 | 0.290 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 412 | 0.290 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 40 | 0.290 |
Why?
| | Vascular Remodeling | 4 | 2025 | 193 | 0.290 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 332 | 0.290 |
Why?
| | Sphingomyelins | 3 | 2025 | 33 | 0.290 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 560 | 0.270 |
Why?
| | Mass Spectrometry | 4 | 2018 | 739 | 0.270 |
Why?
| | Fibrinolysin | 1 | 2007 | 20 | 0.270 |
Why?
| | Heart | 1 | 2011 | 655 | 0.270 |
Why?
| | Transcription Factors | 2 | 2012 | 1719 | 0.260 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 145 | 0.260 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1502 | 0.260 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 622 | 0.250 |
Why?
| | Thrombin | 1 | 2007 | 152 | 0.250 |
Why?
| | Electric Impedance | 3 | 2015 | 107 | 0.250 |
Why?
| | Biomarkers | 8 | 2021 | 4149 | 0.250 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 108 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2607 | 0.240 |
Why?
| | ADAM17 Protein | 2 | 2017 | 35 | 0.240 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 200 | 0.240 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 329 | 0.230 |
Why?
| | Leukocytes | 3 | 2022 | 311 | 0.230 |
Why?
| | Cell Adhesion | 2 | 2020 | 466 | 0.230 |
Why?
| | Caspase 6 | 2 | 2016 | 3 | 0.220 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 132 | 0.220 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.220 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 665 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2691 | 0.210 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 24 | 0.210 |
Why?
| | Capillary Permeability | 2 | 2015 | 145 | 0.210 |
Why?
| | Homeostasis | 3 | 2018 | 621 | 0.210 |
Why?
| | Biomedical Technology | 1 | 2024 | 43 | 0.210 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 13 | 0.210 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 363 | 0.200 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 20 | 0.200 |
Why?
| | Monocytes | 4 | 2023 | 563 | 0.200 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 85 | 0.200 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 60 | 0.200 |
Why?
| | Cell Line | 4 | 2017 | 2847 | 0.200 |
Why?
| | Respiratory System | 1 | 2024 | 157 | 0.190 |
Why?
| | Middle Aged | 11 | 2022 | 33479 | 0.190 |
Why?
| | Oxygen Consumption | 2 | 2022 | 696 | 0.190 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 181 | 0.190 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 94 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2013 | 171 | 0.180 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1272 | 0.180 |
Why?
| | Congresses as Topic | 1 | 2023 | 233 | 0.180 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 257 | 0.180 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.180 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.180 |
Why?
| | Flow Cytometry | 4 | 2015 | 1178 | 0.180 |
Why?
| | Chitinases | 1 | 2021 | 8 | 0.180 |
Why?
| | Influenza A virus | 1 | 2022 | 107 | 0.180 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.180 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 41 | 0.180 |
Why?
| | Cell Size | 1 | 2021 | 91 | 0.180 |
Why?
| | CD11b Antigen | 1 | 2021 | 61 | 0.180 |
Why?
| | Cytoskeleton | 3 | 2011 | 191 | 0.180 |
Why?
| | Lectins | 1 | 2021 | 49 | 0.180 |
Why?
| | Societies, Medical | 2 | 2023 | 820 | 0.180 |
Why?
| | Kinetics | 3 | 2015 | 1670 | 0.170 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.170 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.170 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 30 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 278 | 0.170 |
Why?
| | Blotting, Western | 4 | 2011 | 1226 | 0.170 |
Why?
| | Integrin beta1 | 1 | 2020 | 25 | 0.170 |
Why?
| | Inhalation Exposure | 1 | 2021 | 105 | 0.170 |
Why?
| | Risk Factors | 5 | 2024 | 10388 | 0.170 |
Why?
| | Microtubules | 1 | 2003 | 279 | 0.170 |
Why?
| | Dronabinol | 1 | 2023 | 226 | 0.170 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 86 | 0.170 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 71 | 0.170 |
Why?
| | Stem Cell Niche | 1 | 2020 | 54 | 0.160 |
Why?
| | Lactic Acid | 1 | 2022 | 305 | 0.160 |
Why?
| | Tobacco Smoking | 1 | 2020 | 25 | 0.160 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 66 | 0.160 |
Why?
| | Stromal Cells | 2 | 2017 | 112 | 0.160 |
Why?
| | Sirolimus | 1 | 2021 | 276 | 0.160 |
Why?
| | Ischemia | 2 | 2018 | 409 | 0.160 |
Why?
| | Oxidants | 2 | 2011 | 111 | 0.160 |
Why?
| | Cell Membrane | 3 | 2013 | 738 | 0.160 |
Why?
| | Biological Assay | 2 | 2021 | 124 | 0.160 |
Why?
| | Collagen Type V | 2 | 2009 | 4 | 0.160 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 20 | 0.150 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 175 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2017 | 3556 | 0.150 |
Why?
| | Exercise Test | 1 | 2022 | 625 | 0.150 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 8 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 382 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 443 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.150 |
Why?
| | Paclitaxel | 2 | 2014 | 230 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 164 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 191 | 0.150 |
Why?
| | Eosinophils | 1 | 2021 | 332 | 0.150 |
Why?
| | Cell Survival | 3 | 2018 | 1120 | 0.150 |
Why?
| | Benzylamines | 1 | 2018 | 41 | 0.150 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.150 |
Why?
| | beta Catenin | 1 | 2020 | 253 | 0.150 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 6 | 0.150 |
Why?
| | Oxygen | 2 | 2014 | 931 | 0.140 |
Why?
| | Imipramine | 1 | 2018 | 12 | 0.140 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 40 | 0.140 |
Why?
| | Hot Temperature | 1 | 2021 | 391 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 45 | 0.140 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 81 | 0.140 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 145 | 0.140 |
Why?
| | Gene Expression | 2 | 2021 | 1502 | 0.140 |
Why?
| | Morphine | 2 | 2009 | 158 | 0.140 |
Why?
| | Cell Hypoxia | 4 | 2020 | 226 | 0.140 |
Why?
| | Carbon Monoxide | 1 | 2018 | 81 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2020 | 512 | 0.140 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 76 | 0.140 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 301 | 0.140 |
Why?
| | Adult | 10 | 2022 | 37929 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2020 | 395 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 565 | 0.130 |
Why?
| | Transcriptome | 3 | 2018 | 971 | 0.130 |
Why?
| | THP-1 Cells | 1 | 2016 | 22 | 0.130 |
Why?
| | Bone Marrow | 1 | 2018 | 286 | 0.130 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 25 | 0.130 |
Why?
| | Spinal Cord | 2 | 2009 | 370 | 0.130 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 313 | 0.130 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 88 | 0.130 |
Why?
| | Adipocytes | 1 | 2018 | 222 | 0.130 |
Why?
| | Time Factors | 3 | 2018 | 6828 | 0.120 |
Why?
| | Bronchi | 1 | 2017 | 260 | 0.120 |
Why?
| | Protein Binding | 3 | 2018 | 2224 | 0.120 |
Why?
| | Lung Transplantation | 2 | 2009 | 313 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 319 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 212 | 0.120 |
Why?
| | Pandemics | 2 | 2021 | 1639 | 0.120 |
Why?
| | Monocrotaline | 1 | 2015 | 28 | 0.120 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 81 | 0.120 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 88 | 0.120 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 52 | 0.120 |
Why?
| | Ventricular Pressure | 1 | 2015 | 48 | 0.120 |
Why?
| | Actins | 3 | 2018 | 416 | 0.120 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 377 | 0.120 |
Why?
| | Neutrophils | 1 | 2021 | 1238 | 0.120 |
Why?
| | Aging | 2 | 2021 | 1864 | 0.120 |
Why?
| | Myelopoiesis | 1 | 2015 | 8 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.120 |
Why?
| | Binding, Competitive | 1 | 2015 | 202 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.120 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 78 | 0.110 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 144 | 0.110 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 110 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 406 | 0.110 |
Why?
| | Collagen Type VI | 1 | 2014 | 6 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 308 | 0.110 |
Why?
| | Hexuronic Acids | 1 | 2014 | 23 | 0.110 |
Why?
| | Glucuronic Acid | 1 | 2014 | 25 | 0.110 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2828 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 269 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 204 | 0.110 |
Why?
| | Arterial Pressure | 1 | 2015 | 126 | 0.110 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 39 | 0.110 |
Why?
| | Propylene Glycols | 2 | 2014 | 28 | 0.110 |
Why?
| | Hyperoxia | 1 | 2015 | 90 | 0.110 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 51 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 455 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 72 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 350 | 0.110 |
Why?
| | HMGB1 Protein | 1 | 2014 | 50 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 2295 | 0.110 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 238 | 0.110 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 60 | 0.100 |
Why?
| | Ligands | 3 | 2023 | 664 | 0.100 |
Why?
| | Paracrine Communication | 1 | 2014 | 65 | 0.100 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 54 | 0.100 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 266 | 0.100 |
Why?
| | Oligopeptides | 2 | 2014 | 271 | 0.100 |
Why?
| | HIV Infections | 3 | 2017 | 2836 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.100 |
Why?
| | Glycolysis | 1 | 2015 | 321 | 0.100 |
Why?
| | Virulence | 1 | 2014 | 267 | 0.100 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 6 | 0.100 |
Why?
| | Calpain | 1 | 2013 | 59 | 0.100 |
Why?
| | United States | 4 | 2024 | 14841 | 0.100 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 36 | 0.100 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 17 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 545 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 442 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 25 | 0.100 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 76 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2031 | 0.100 |
Why?
| | Cattle | 3 | 2008 | 984 | 0.100 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 285 | 0.100 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 45 | 0.100 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 320 | 0.100 |
Why?
| | Lung Compliance | 1 | 2012 | 49 | 0.100 |
Why?
| | Neuralgia | 1 | 2014 | 133 | 0.100 |
Why?
| | Proteolysis | 1 | 2013 | 177 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2189 | 0.100 |
Why?
| | Drug Tolerance | 2 | 2009 | 105 | 0.090 |
Why?
| | Liposomes | 1 | 2014 | 223 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 45 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 75 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5472 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 64 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 437 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 165 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 7 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 130 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.090 |
Why?
| | Bronchioles | 1 | 2011 | 23 | 0.090 |
Why?
| | Goblet Cells | 1 | 2011 | 22 | 0.090 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 150 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1062 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 372 | 0.090 |
Why?
| | Permeability | 1 | 2011 | 161 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 149 | 0.090 |
Why?
| | Immunization, Passive | 1 | 2011 | 90 | 0.090 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.090 |
Why?
| | Inflammasomes | 1 | 2012 | 131 | 0.090 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 220 | 0.090 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 1000 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2011 | 145 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1759 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2010 | 134 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 409 | 0.080 |
Why?
| | Carcinogens | 1 | 2011 | 125 | 0.080 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 56 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 202 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 594 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 409 | 0.080 |
Why?
| | Perfusion | 1 | 2011 | 213 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 194 | 0.080 |
Why?
| | Exercise | 1 | 2022 | 2057 | 0.080 |
Why?
| | Aged | 5 | 2020 | 23961 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 45 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 1002 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 553 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 129 | 0.080 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 9 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 429 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2833 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 430 | 0.080 |
Why?
| | Clathrin | 1 | 2009 | 27 | 0.080 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 36 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1060 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1738 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2013 | 706 | 0.080 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 93 | 0.080 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 416 | 0.080 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 13 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3958 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 788 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 93 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 105 | 0.070 |
Why?
| | Protein Precursors | 1 | 2009 | 134 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1457 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3412 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 890 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 213 | 0.070 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 12 | 0.070 |
Why?
| | Software | 1 | 2013 | 665 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 828 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 261 | 0.070 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 49 | 0.070 |
Why?
| | Cyclosporine | 1 | 2009 | 268 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 283 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 2071 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 34 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 286 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 257 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 156 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 367 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 57 | 0.070 |
Why?
| | Obesity | 2 | 2020 | 2992 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 202 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 328 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 298 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 477 | 0.070 |
Why?
| | Cell-Free System | 1 | 2006 | 53 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2023 | 744 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2531 | 0.060 |
Why?
| | Indoles | 1 | 2009 | 412 | 0.060 |
Why?
| | Cisplatin | 1 | 2008 | 320 | 0.060 |
Why?
| | Capillaries | 1 | 2006 | 108 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1081 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Antigens, CD | 2 | 2011 | 521 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 624 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 193 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 54 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1724 | 0.060 |
Why?
| | Acyltransferases | 1 | 2005 | 57 | 0.060 |
Why?
| | Deoxyguanosine | 1 | 2004 | 25 | 0.060 |
Why?
| | Weight Loss | 1 | 2010 | 787 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1786 | 0.060 |
Why?
| | Regeneration | 1 | 2006 | 197 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2757 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 893 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 11 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 19 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 25 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 48 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 87 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 135 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 83 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 565 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1430 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 398 | 0.050 |
Why?
| | Imidazoles | 1 | 2003 | 238 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 313 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 315 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 385 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 313 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2526 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1496 | 0.040 |
Why?
| | Fever | 1 | 2022 | 306 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2129 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 87 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1590 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 506 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 110 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 767 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 36 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 771 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 294 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 688 | 0.040 |
Why?
| | Swine | 1 | 2021 | 775 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 350 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5742 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 366 | 0.040 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 22 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 247 | 0.040 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.040 |
Why?
| | Propionates | 1 | 2018 | 39 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 518 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1070 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 176 | 0.030 |
Why?
| | Vital Capacity | 1 | 2018 | 311 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.030 |
Why?
| | Nitriles | 1 | 2018 | 172 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 125 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 145 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1431 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1111 | 0.030 |
Why?
| | RNA | 1 | 2023 | 921 | 0.030 |
Why?
| | HIV | 1 | 2017 | 234 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 243 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 519 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 786 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 121 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1793 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 584 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2074 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 691 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 155 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 57 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 81 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 275 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 107 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1020 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 139 | 0.030 |
Why?
| | Indans | 1 | 2014 | 11 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 33 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 138 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 13209 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 329 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 532 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 73 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 257 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 367 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 15657 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 600 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 123 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 93 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 109 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 117 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 91 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 161 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 803 | 0.030 |
Why?
| | Cricetinae | 1 | 2013 | 289 | 0.030 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 6 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1710 | 0.030 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 21 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 601 | 0.030 |
Why?
| | Lipid Bilayers | 1 | 2014 | 98 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 147 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 48 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 48 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 153 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 135 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 844 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 39 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 178 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 558 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 191 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 513 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 327 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 222 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1208 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 978 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 60 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 79 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 528 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1946 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 176 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 385 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2186 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 114 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 58 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 82 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 126 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2409 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 514 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 12 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 239 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 100 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 54 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1357 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 161 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 816 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7635 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 872 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1066 | 0.020 |
Why?
| | Postural Balance | 1 | 2008 | 215 | 0.020 |
Why?
| | Pleura | 1 | 2005 | 23 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1704 | 0.020 |
Why?
| | Ligation | 1 | 2005 | 92 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 124 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 119 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 847 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 402 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 226 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 90 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 985 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1996 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10811 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1783 | 0.010 |
Why?
| | Child | 1 | 2017 | 21935 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|